Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03014544 · ClinicalTrials.gov registry record
Study to Evaluate the Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Test Battery in Participants With Major Depressive Disorder (MDD)
A clinical trial, sponsored by Janssen Research & Development.
- Completed
- Registry status
- 585
- Enrollment target
NCT03014544: Completed study, sponsored by Janssen Research & Development.
NCT03014544 is a clinical trial that has completed, run by Janssen Research & Development. The registered enrollment target is 585 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03014544 has completed, sponsored by Janssen Research & Development.
- COMPLETED
- Registry status
- 585 participants
- Enrollment target
Study Summary
The purpose of this study is to examine concurrent validity of 8 computerized tests intended for the assessment of cognitive function in participants with Major Depressive Disorder (MDD), relative to 8 corresponding and previously validated examiner-administered cognitive tests.
Primary Outcome
The SST is designed as a measure of executive function. The SST requires the participant to sort symbols, based on symbol features such as color, shape, and number. No sorting criteria are provided to participants, rather the participant is provided feedback whether his/her response is correct or incorrect. Responses will be scored for Categories Achieved and Percent Perseverative Errors by computerized cognitive test battery.
Interventions
- DEVICE Computer- administered test battery
- DEVICE Examiner- administered test battery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 585 participants |
| Start Date | 2016-10-26 |
| Est. Completion | 2019-04-08 |
What the finished NCT03014544 record still lists
NCT03014544 is an observational study that tracks outcomes without assigning an intervention. The registered 585 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Computer- administered test battery is the first listed.
NCT03014544 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03014544 about?
NCT03014544 is a clinical study titled "Study to Evaluate the Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Test Battery in Participants With Major Depressive Disorder (MDD)". The purpose of this study is to examine concurrent validity of 8 computerized tests intended for the assessment of cognitive function in participants with Major Depressive Disorder (MDD), relative to 8 corresponding and previously validated examiner-administered cognitive tests.
What is the current status of trial NCT03014544?
This trial is currently completed. The enrollment target is 585 participants. The study started on 2016-10-26. Estimated completion is 2019-04-08.
What interventions are being tested in trial NCT03014544?
The interventions under investigation include: Computer- administered test battery (DEVICE), Examiner- administered test battery (DEVICE).
Who is sponsoring clinical trial NCT03014544?
This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02803957 · 585 participants · NA
Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair
- NCT06680869 · 585 participants · Phase 3
Early Amiodarone in Shockable Cardiac Arrest
- NCT04134260 · 586 participants · Phase 3
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial
- NCT06100770 · 586 participants
Aveir AR Coverage With Evidence Development (CED) Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI